Takeda Pharmaceutical (TAK)

• Market cap: $48.8B
• 1 day: 2.79%
• 5 days: -3.56%
• 1 month: -6.7%
• 3 months: -15.2%
• 6 months: 8.19%
• Year to date: -1.09%
• 1 year: 2.79%
• 5 years: -7.6%
• 10 years: -7.15%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Employees: 47,455